Abstract
Adriamycin, a new antitumour antibiotic of the anthracycline group with a structural formula very similar to daunorubicin, has proved to have potent tumour-growth-inhibiting properties, and to be particularly effective in childhood malignancies. Though adriamycin produces a higher percentage of side-effects than daunorubicin—namely, stomatitis and alopecia—a lower dosage may be used for therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boiron M., Weil M., Jacquillat C., Tanzer J., Levy D., Sultan C., Bernard J. Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet. 1969 Feb 15;1(7590):330–333. doi: 10.1016/s0140-6736(69)91296-3. [DOI] [PubMed] [Google Scholar]
- Bonadonna G., Monfardini S. Cardiac toxicity of daunorubicin. Lancet. 1969 Apr 19;1(7599):837–837. [PubMed] [Google Scholar]
- Bonadonna G., Monfardini S., Guindani A. Terapia con daunomicina nelle malattie linforproliferative croniche. Tumori. 1968 Nov-Dec;54(6):465–481. doi: 10.1177/030089166805400605. [DOI] [PubMed] [Google Scholar]
- Di Marco A., Gaetani M., Scarpinato B. Adriamycin (NSC-123,127): a new antibiotic with antitumor activity. Cancer Chemother Rep. 1969 Feb;53(1):33–37. [PubMed] [Google Scholar]
- KARNOFSKY D. A. Meaningful clinical classification of therapeutic responses to anticancer drugs. Clin Pharmacol Ther. 1961 Nov-Dec;2:709–712. doi: 10.1002/cpt196126709. [DOI] [PubMed] [Google Scholar]
- Macrez C., Marneffe-Lebrequier H., Ripault J., Clauvel J. P., Jacquillat C., Weil M. Accidents cardiaques observés au cours des traitements par la rubidomycine. Pathol Biol. 1967 Oct;15(19):949–953. [PubMed] [Google Scholar]
- Malpas J. S., Scott R. B. Daunorubicin in acute myelocytic leukaemia. Lancet. 1969 Mar 1;1(7592):469–470. doi: 10.1016/s0140-6736(69)91516-5. [DOI] [PubMed] [Google Scholar]
- Malpas J. S., Scott R. B. Rubidomycin in acute leukaemia in adults. Br Med J. 1968 Jul 27;3(5612):227–229. doi: 10.1136/bmj.3.5612.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marmont A. M., Damasio E., Rossi F. Cardiac toxicity of daunorubicin. Lancet. 1969 Apr 19;1(7599):837–838. [PubMed] [Google Scholar]
- Tan C., Tasaka H., Yu K. P., Murphy M. L., Karnofsky D. A. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer. 1967 Mar;20(3):333–353. doi: 10.1002/1097-0142(1967)20:3<333::aid-cncr2820200302>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]